Thursday broker round-up
27th Sep 2018 12:14
(Sharecast News) - Thomas Cook Group: UBS upgrades to neutral with a target price of 60p.
Read moreClinigen announces two new acquisition targets following 'another year of good progress'
27th Sep 2018 08:04
(Sharecast News) - Clinigen plans to raise £80m from investors to fund two new acquisitions following a "strong performance" from one of its previous additions in its last trading year.
Read moreClinigen makes second July drug acquisition
25th Jul 2018 14:40
(Sharecast News) - Pharmaceutical and services company Clinigen has acquired the global rights to severe malignant osteoperosis treatment Imukin from Horizon Pharma for an undisclosed sum.
Read moreClinigen profits rise by a third
25th Jan 2017 16:47
(ShareCast News) - Global pharmaceutical and services company Clinigen Group provided a trading update for the six months to 31 December on Wednesday, with gross profit up 34%. The AIM-traded firm said this was driven by a combination of "good" organic growth across all divisions, a full six months
Read moreClinigen division teams up with TESARO
17th Jan 2017 14:10
(ShareCast News) - Clinigen Group announced on Tuesday that its Idis Managed Access division has partnered with TESARO to launch a managed access program for the investigational PARP 1/2 inhibitor, niraparib. The AIM-traded company said Niraparib is being made available for eligible women in the U.S
Read moreClinigen enters into second agreement with Cumberland Pharmaceuticals
9th Jan 2017 15:57
(ShareCast News) - Clinigen Group, an AIM listed global pharmaceutical and services company, and Cumberland Pharmaceuticals, a US specialty pharmaceutical company have entered into their second exclusive agreement to commercialise the oncology support drug Totect in the US. The first product Clinige
Read moreClinigen to distribute BioQ's pain relief drug in Europe
15th Dec 2016 09:08
(ShareCast News) - AIM-listed pharmaceutical Clinigen is to distribute BioQ Pharma's post-surgery pain management drug, Ropivacaine Readyfusor. The company's subsidiary Idis Global Access has agreed to supply and distribute the pre-filled Ropivacaine Readyfusor for post-operative pain management in
Read moreClinigen and Eisai launch breast cancer treatment in South Africa
1st Dec 2016 11:03
(ShareCast News) - Pharmaceutical companies Clinigen and Eisai launched an advanced breast cancer treatment for women in South Africa called Halaven (eribulin). The treatment will benefit around 7,000 women in South Africa that are diagnosed with breast cancer each year. Halaven is now registered b
Read moreDirector dealings: Clinigen's Bacon slices off a chunk
14th Nov 2016 15:07
(ShareCast News) - Clinigen Group director John Bacon has sold £1.4m of the pharmaceuticals and clinical trial services group. Bacon sold 200,000 shares at a price of 717p apiece, but still holds 730,767 shares in the company. He had originally joined the board as a non-executive director last year
Read moreClinigen says trading in-line for current FY
11th Nov 2016 13:40
(ShareCast News) - Global pharmaceutical and services company Clinigen Group said its trading for the current financial year is in-line with directors' expectations. It said the year to 30 June marked the completion of its transformation into the global market leader in the management and supply of
Read moreSunday newspaper round-up: More 'Nissan' deals, Carney, RBS, HSBC, Capita
30th Oct 2016 14:52
(ShareCast News) - Pharmaceuticals giants want the government to plug a £1bn-a-year funding gap that will be created when Britain leaves the EU, as part of a list of demands being drawn up by big business after last week's deal with Nissan. After the Japanese car maker said it would make two new mod
Read moreClinigen Group extends partnership with BTG
25th Oct 2016 08:50
(ShareCast News) - AIM-listed pharmaceutical Clinigen Group's Idis Global Access division extended its four-year partnership with BTG, a healthcare company, to manage its critical care portfolio across the whole of Europe and new territories in Asia. The agreement now includes all of Europe and some
Read moreClinigen expands operations into Japan
18th Oct 2016 08:36
(ShareCast News) - Clinigen Group, an AIM listed global pharmaceuticals and services company, has extended its geographical reach to Japan with the opening of a new office in Tokyo. Clinigen KK further expands the group's presence in Asia following the company's acquisition of Link healthcare in 201
Read moreClinigen Group issues 38k option shares
22nd Jul 2016 10:21
(ShareCast News) - Clinigen Group announced on Friday that it has made an application for the admission to trading on AIM of 38,308 ordinary shares of 0.1p each. The firm said the shares have been issued to satisfy the exercise of share options, and rank pari passu with the existing shares of the gr
Read moreClinigen revenue and profits see serious rise
20th Jul 2016 14:42
(ShareCast News) - Global pharmaceutical and services company Clinigen Group posted a trading update for the year to 30 June on Wednesday, reporting an 87% improvement in revenue and a 90% increase in gross profit. The AIM-traded firm said the growth was driven primarily by acquisitions and organic
Read more